Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001628280-25-039623
Filing Date
2025-08-11
Accepted
2025-08-11 16:48:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 ngne-2025atmprospectussupp.htm 424B5 300167
2 neurogene.jpg GRAPHIC 7687
3 prospectusa.jpg GRAPHIC 7680
  Complete submission text file 0001628280-25-039623.txt   322877
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-286057 | Film No.: 251202679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)